EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Emerging Technologies in Automation Machinery for the Pharmaceutical Industry

    Pharmaceutical industry has long been a forerunner on the use of technology where it has proved vital in increasing efficiency quality and safety Automation machinery has become more important over the years due to its ability to efficiently handle manufacturing packaging and distribution challenges Advanced technology is improving automation machinery as an integration tool in the pharmaceutical...

    How Pharma 4.0 Is Revolutionizing Drug Manufacturing

    The pharmaceutical industry in the world is experiencing a digital transformation rejuvenated by the advent of Pharma an industry phenomenon that is based on Industry Due to the readjustment of the manufacturing industry to Industry the automation data interchange and intelligent ecosystem the pharmaceutical ecosystem is similarly being reorganized with Pharma technologies Research and develo...

    Advancing Pharmacovigilance Talent for AI: Overcoming Skills and Resource Barriers

    In the transforming field of pharmacovigilance PV artificial intelligence AI is reshaping how drug safety is monitored and managed As PV evolves from manual reactive workflows to sophisticated AIaugmented systems the imperative for comprehensive workforce upskilling grows stronger Organisations and professionals must adapt to new technical demands regulatory requirements and ethical challenges to...

    Acquisitions of Small-Medium Pharma Companies in EU

    In EU the middleclass in Pharma is disappearing companies with revenues by M with a small factory and operations limited to some few countries

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Since initial reports from Wuhan China in December and the subsequent declaration of a global pandemic by the WHO in March CoVID has precipitated the greatest health crisis in modern history While exposing fundamental weaknesses in healthcare systems across the globe this tragedy has also been an opportunity for scientists and researchers in different fields to collaborate and produce solutions...

    Cybersecurity in Pharma: The Threat No One Budgeted For

    There is a particular kind of risk that organisations are bad at pricing the one that has never happened to them Pharmaceutical companies have spent a generation building sophisticated defences against the risks they know intimatelycontamination adulteration deviation recall Quality systems are mature inspectionready and deeply funded Cyber risk has never enjoyed that status It sat in the IT budge...

TOP ARTICLES

  • 1

    How Pharma 4.0 Is Revolutionizing Drug Manufacturing

    Kate Williamson

    Pharma 4.0 is a digital revolution in the pharmaceutical business, which combines AI, IoT, automation, and data analytics to revolutionize drug production. It advances smarter pharmaceutical productio...

  • 3

    Acquisitions of Small-Medium Pharma Companies in EU

    Angel Calvo Yague

    In EU the “middle-class” in Pharma is disappearing; companies with revenues by 50 – 100 M€, with a small factory and operations limited to some few countries, belonging to a fam...

  • 4

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Smriti Sharma Bhatia

    Yousuf Khan

    Kunika Saini

    QSAR modelling has been used extensively as an efficient method in the process of drug development against CoVID-19. The rapid spread and devastating impact of this viral disease across the globe requ...

press releases Read more...

PhenoNet Cleared by FDA to Begin Phase 3 Trial of Inhaled PHENOGENE-1A in Early Alzheimer's Disease

PhenoNet Inc announced that the US Food and Drug Administration FDA has notified the company that it may proceed with a Phase clinical trial of its lead candidate PHENOGENEA

Olympia Pharmaceuticals Advances Longevity Offerings With Advanced Injectable CoQ10 Formulation

Olympia Pharmaceuticals a premier FDAregistered B outsourcing facility and A pharmacy today announced the launch of its new Coenzyme Q CoQ injectable formulation Expanding Olympi

AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)

AC Immune SA NASDAQ ACIU a clinicalstage biopharmaceutical company developing targeted therapeutics for neurodegenerative diseases today announced that it has received Fast Track designation and clearance

Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia

Graviton BioScience Corporation a privately held clinicalstage biotechnology company developing a diverse pipeline of therapeutics including selective ROCK inhibitors for metabolic inflammatory fibrotic

19 - 21

Aug 2026

20 - 21

Aug 2026

20 - 21

Aug 2026

20 - 21

Aug 2026

25 - 27

Aug 2026

CPHI Korea 2026

COEX, Seoul, Korea

26 - 27

Aug 2026

BIOMEDevice 2026

Boston Convention & Exhibition...

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

LATEST NEWS Read more...

Eurofins CDMO Alphora Expands Kilolab and High-Potency Development and Manufacturing Capabilities

Eurofins CDMO Alphora has expanded its kilolab and highpotency active pharmaceutical ingredient HPAPI development and manufacturing capabilities at its Mississauga site

Amprion Partners with MLM Medical Labs to Expand Alpha-Synuclein Testing in Europe

Amprion has entered into a strategic licensing agreement with MLM Medical Labs to expand access to alphasynuclein seed amplification assay SAA testing for biopharmaceutical clinical trials across Europe

Tasman Therapeutics Partners with Osmind to Advance R-107 for Depressive Disorders

Tasman Therapeutics has entered into a multiyear strategic partnership with Osmind to support the development of R an investigational oral ketamine treatment for treatmentresistant depression TRD

Mereo BioPharma and Sentynl Therapeutics Sign Option and Licence Agreement for Alvelestat

Mereo BioPharma Group and Sentynl Therapeutics a wholly owned subsidiary of Zydus Lifesciences have entered into an option and licence agreement covering the US commercial and global manufacturing rights to alvelestat for alpha antitrypsin deficiencyassociated lung disease AATDLD

Boehringer Ingelheim Acquires Evax to Expand Equine Health Pipeline

Boehringer Ingelheim has acquired Evax AG a Swiss biotechnology company developing therapeutic vaccines for equine health

Altasciences Expands North American Bioanalytical Laboratory Capacity

Altasciences is expanding its bioanalytical laboratory operations in North America to increase capacity and support faster drug development